华绿生物
(300970)
| 流通市值：11.05亿 | | | 总市值：14.27亿 |
| 流通股本：9306.09万 | | | 总股本：1.20亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 336,854,042.32 | 316,089,705.13 | 336,898,188.19 | 409,952,778.49 |
| 应收票据及应收账款 | 19,492,553.01 | 16,468,266.94 | 19,968,064.1 | 18,685,725.04 |
| 应收账款 | 19,492,553.01 | 16,468,266.94 | 19,968,064.1 | 18,685,725.04 |
| 预付款项 | 6,416,118.78 | 9,046,762.52 | 4,550,065.87 | 6,147,736.21 |
| 其他应收款合计 | 3,528,853.44 | 3,099,156.44 | 3,698,956.67 | 3,521,697.69 |
| 其中:应收利息 | 1,229,569.93 | 1,063,213.75 | 1,243,709.16 | 1,552,387.22 |
| 存货 | 193,503,698.53 | 181,385,415.8 | 178,406,941.41 | 188,202,443.04 |
| 其他流动资产 | 1,958,047.77 | 867,166.4 | 956,264.11 | 1,340,768.94 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 561,753,313.85 | 526,956,473.23 | 544,478,480.35 | 627,851,149.41 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 393,808.26 | 396,183.84 | 536,524.97 | 503,876.27 |
| 固定资产 | 1,201,875,559.45 | 1,173,626,423.59 | 1,199,596,769.94 | 1,225,629,761.25 |
| 在建工程 | 206,164,118.02 | 200,377,368.23 | 127,614,321.85 | 93,557,615.49 |
| 使用权资产 | 212,660,548.87 | 80,269,267.7 | 85,735,341.17 | 90,788,414.64 |
| 无形资产 | 57,248,019.48 | 57,681,114.21 | 58,114,208.94 | 58,547,303.71 |
| 长期待摊费用 | 69,144.45 | 134,458.59 | 200,716.86 | 268,862.79 |
| 其他非流动资产 | 63,299,694.99 | 52,397,745.61 | 34,397,322.87 | 21,823,424.43 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,741,710,893.52 | 1,564,882,561.77 | 1,506,195,206.6 | 1,491,119,258.58 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,303,464,207.37 | 2,091,839,035 | 2,050,673,686.95 | 2,118,970,407.99 |
| 流动负债: | | | | |
| 短期借款 | 20,011,361.14 | 20,013,916.67 | - | - |
| 应付票据及应付账款 | 71,530,494.96 | 80,256,159.68 | 72,728,321.13 | 78,525,974.52 |
| 应付账款 | 71,530,494.96 | 80,256,159.68 | 72,728,321.13 | 78,525,974.52 |
| 预收款项 | - | - | 2,869,194.28 | - |
| 合同负债 | 2,683,045.31 | 3,041,540.99 | - | 3,635,972.95 |
| 应付职工薪酬 | 25,421,450.29 | 24,652,427.54 | 23,996,463.04 | 28,106,522.52 |
| 应交税费 | 239,697.46 | 243,399.72 | 209,230.4 | 257,873.01 |
| 其他应付款合计 | 53,175,080.2 | 59,030,531.9 | 50,948,230.17 | 59,420,139.72 |
| 一年内到期的非流动负债 | 5,856,355.63 | 14,235,679.15 | 42,086,824.89 | 63,826,661.9 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 178,917,484.99 | 201,473,655.65 | 192,838,263.91 | 233,773,144.62 |
| 非流动负债: | | | | |
| 长期借款 | 335,672,047.53 | 260,754,507.1 | 163,763,444.23 | 170,412,821.96 |
| 租赁负债 | - | 100,672,446.28 | - | 99,095,668.18 |
| 长期应付款 | 238,259,836.34 | - | 99,884,057.23 | 99,095,668.18 |
| 递延收益 | - | 43,417,868.98 | - | 47,749,115.2 |
| 其他非流动负债 | 48,193,912.54 | - | 45,583,492.09 | 47,749,115.2 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 622,125,796.41 | 404,844,822.36 | 309,230,993.55 | 317,257,605.34 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 801,043,281.4 | 606,318,478.01 | 502,069,257.46 | 551,030,749.96 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 117,888,600 | 117,888,600 | 117,888,600 | 117,888,600 |
| 资本公积 | 890,709,499.86 | 885,326,997.6 | 879,218,886.09 | 873,013,614.58 |
| 减:库存股 | 30,012,706.01 | 30,012,706.01 | 30,012,706.01 | - |
| 盈余公积 | 21,976,268.59 | 21,976,268.59 | 21,976,268.59 | 21,976,268.59 |
| 未分配利润 | 476,577,065.4 | 466,842,447.39 | 536,514,868.72 | 534,775,322.44 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,477,138,727.84 | 1,462,021,607.57 | 1,525,585,917.39 | 1,547,653,805.61 |
| 少数股东权益 | 25,282,198.13 | 23,498,949.42 | 23,018,512.1 | 20,285,852.42 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,502,420,925.97 | 1,485,520,556.99 | 1,548,604,429.49 | 1,567,939,658.03 |
| 负债和股东权益合计 | 2,303,464,207.37 | 2,091,839,035 | 2,050,673,686.95 | 2,118,970,407.99 |
| 公告日期 | 2024-10-29 | 2024-08-28 | 2024-04-23 | 2024-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |